Teachers Retirement System of The State of Kentucky Increases Position in DaVita Inc. $DVA

Teachers Retirement System of The State of Kentucky increased its position in shares of DaVita Inc. (NYSE:DVAFree Report) by 20.2% during the 1st quarter, Holdings Channel reports. The firm owned 225,177 shares of the company’s stock after acquiring an additional 37,800 shares during the period. Teachers Retirement System of The State of Kentucky’s holdings in DaVita were worth $34,607,000 at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of the company. Invesco Ltd. increased its stake in DaVita by 2.0% in the 3rd quarter. Invesco Ltd. now owns 1,679,248 shares of the company’s stock worth $223,122,000 after buying an additional 32,358 shares in the last quarter. Morgan Stanley lifted its position in shares of DaVita by 5.1% in the fourth quarter. Morgan Stanley now owns 1,477,045 shares of the company’s stock valued at $167,807,000 after acquiring an additional 71,156 shares in the last quarter. Arrowstreet Capital Limited Partnership lifted its position in shares of DaVita by 114.9% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 1,190,000 shares of the company’s stock valued at $135,196,000 after acquiring an additional 636,191 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in shares of DaVita by 0.3% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,089,100 shares of the company’s stock worth $123,733,000 after acquiring an additional 3,507 shares during the period. Finally, LSV Asset Management grew its position in shares of DaVita by 1.1% during the fourth quarter. LSV Asset Management now owns 936,768 shares of the company’s stock worth $106,426,000 after purchasing an additional 9,739 shares in the last quarter. Institutional investors own 90.12% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms recently commented on DVA. Deutsche Bank Aktiengesellschaft raised DaVita from a “hold” rating to a “buy” rating and boosted their price target for the stock from $126.00 to $220.00 in a report on Wednesday, May 6th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of DaVita in a report on Monday, June 8th. Truist Financial lifted their price objective on shares of DaVita from $158.00 to $205.00 and gave the company a “hold” rating in a research report on Friday, May 8th. Zacks Research lowered shares of DaVita from a “strong-buy” rating to a “hold” rating in a research report on Monday, July 6th. Finally, UBS Group raised their target price on shares of DaVita from $235.00 to $270.00 and gave the company a “buy” rating in a research note on Friday. Two equities research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $209.00.

Read Our Latest Stock Analysis on DVA

Insider Buying and Selling at DaVita

In other news, insider Kathleen Alyce Waters sold 15,405 shares of the company’s stock in a transaction dated Monday, June 15th. The shares were sold at an average price of $208.40, for a total transaction of $3,210,402.00. Following the sale, the insider directly owned 109,194 shares in the company, valued at approximately $22,756,029.60. This represents a 12.36% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Joel Ackerman sold 51,471 shares of the stock in a transaction dated Thursday, May 7th. The shares were sold at an average price of $192.10, for a total transaction of $9,887,579.10. Following the completion of the transaction, the chief financial officer directly owned 132,434 shares of the company’s stock, valued at approximately $25,440,571.40. The trade was a 27.99% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 1.50% of the stock is owned by company insiders.

DaVita Price Performance

Shares of DVA opened at $232.51 on Monday. The stock has a market capitalization of $14.93 billion, a price-to-earnings ratio of 21.57, a price-to-earnings-growth ratio of 0.76 and a beta of 0.88. DaVita Inc. has a 1 year low of $101.00 and a 1 year high of $239.64. The business’s 50 day simple moving average is $204.50 and its 200-day simple moving average is $160.63.

DaVita (NYSE:DVAGet Free Report) last posted its earnings results on Tuesday, May 5th. The company reported $2.87 earnings per share for the quarter, beating analysts’ consensus estimates of $2.33 by $0.54. DaVita had a net margin of 5.65% and a negative return on equity of 270.37%. The firm had revenue of $3.42 billion during the quarter, compared to analyst estimates of $3.36 billion. During the same period last year, the firm posted $2.00 earnings per share. DaVita’s revenue for the quarter was up 6.0% compared to the same quarter last year. DaVita has set its FY 2026 guidance at 14.100-15.200 EPS. On average, sell-side analysts expect that DaVita Inc. will post 15.07 earnings per share for the current year.

DaVita Profile

(Free Report)

DaVita Inc (NYSE: DVA) is a leading provider of kidney care services, specializing in the management and operation of outpatient dialysis centers for patients with chronic kidney failure and end-stage renal disease. Headquartered in Denver, Colorado, the company offers a comprehensive suite of treatment modalities, including in-center hemodialysis, peritoneal dialysis, and home dialysis therapies. In addition to its core dialysis services, DaVita provides patient education, nutritional counseling, vascular access management and related laboratory services to support kidney health and overall patient well-being.

Since its formation in the mid-1990s through a clinical management services spin-off, DaVita has expanded both organically and through strategic partnerships and acquisitions.

Featured Articles

Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DaVita Inc. (NYSE:DVAFree Report).

Institutional Ownership by Quarter for DaVita (NYSE:DVA)

Receive News & Ratings for DaVita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita and related companies with MarketBeat.com's FREE daily email newsletter.